The Global Fund, PEPFAR, CIFF, and BMGF are collaborating to provide affordable access to lenacapavir for HIV prevention, aiming to reach at least 2 million people in three years. Gilead Sciences’ lenacapavir is showing promise in preventing new HIV infections and has been licensed for manufacturing in low- and lower-middle-income countries. The goal is to accelerate progress towards ending HIV/AIDS as a public health threat by 2030 through widespread access to this innovative treatment.
Full Article
Mali charges ex-PM Moussa Mara with undermining the state in X post
A former prime minister of Mali, Moussa Mara, has been charged with undermining the state's credibility after expressing support for detained opposition figures on social media. Detained for questioning by the cybercrime unit, he faces accusations of opposing legitimate authority and inciting public disorder, with a trial set for September 29, amid ongoing military rule since recent coups. Want More Context? 🔎
Read more